News Daily News Expert Consensus Aims to Promote Cardiac CT Use in Preprocedural LAA Occlusion Yael L. Maxwell November 01, 2019
News Daily News Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease L.A. McKeown November 01, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2019 Todd Neale October 31, 2019
News Daily News Better Closure, More A-fib With Cardioform for PFO Closure: Retrospective Series Yael L. Maxwell October 30, 2019
News Daily News New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR Todd Neale October 18, 2019
News Conference News TCT 2019 Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences L.A. McKeown October 09, 2019
News Conference News TCT 2019 Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA Todd Neale October 04, 2019
Presentation TCT Abstracts Posters 2019 In-hospital Outcomes of Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation: Nationwide Database Analysis Presenter: Fangcheng Wu September 29, 2019
News Conference News TCT 2019 TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 Yael L. Maxwell September 29, 2019
News Conference News TCT 2019 Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR Todd Neale September 29, 2019
News Conference News TCT 2019 Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA Michael O'Riordan September 28, 2019
News Conference News TCT 2019 Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis Michael O'Riordan September 27, 2019
Presentation TCT 2019 TAVR and Concomitant Atrial Fibrillation: Case Presentation Presenter: Fabian Nietlispach September 27, 2019
News Conference News TCT 2019 Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients Yael L. Maxwell September 27, 2019
Presentation TCT 2019 Epicardial LAAC to Reduce Atrial Fibrillation: AMAZE Rationale and Status Presenter: DJ Lakkireddy September 26, 2019
Presentation TCT 2019 AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome Presenter: Stephan Windecker September 26, 2019
News Conference News ESC 2019 Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints Todd Neale September 11, 2019
News Conference News ESC 2019 LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17 Todd Neale September 10, 2019